Analyzing high dimensional data based on hypothesis testing for assessing similarity between complex organic molecules using mass spectrometry

A technology of organic molecules and hypothesis testing, which is applied to the analysis of materials, material inspection products, chemical data mining, etc.

Pending Publication Date: 2020-12-18
SCINOPHARM TAIWAN LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, no two GAs can be proven to be "identical"

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Analyzing high dimensional data based on hypothesis testing for assessing similarity between complex organic molecules using mass spectrometry
  • Analyzing high dimensional data based on hypothesis testing for assessing similarity between complex organic molecules using mass spectrometry
  • Analyzing high dimensional data based on hypothesis testing for assessing similarity between complex organic molecules using mass spectrometry

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Sample Preparation

[0029] Copolymer-1 (20 mg, available from Sigma-Aldrich (St.Louis, MO)) or GA (20 mg, ScinoPharm Taiwan Ltd.) was dissolved in 1 mL of mannitol (40 mg / mL) at the same concentration as Kepasone, And seven replicate samples of copolymer-1 or GA were prepared from 30 μL of the solution. 10 samples were prepared from each batch of 30 μL Kepasone. For digestion, 45 μL of distilled deionized water (ddH 2 O), 18 μL of ammonium bicarbonate (24 mg / mL, adjusted to pH 8.40), and 15 μL of Lys-C (0.2 g / L). These samples were incubated in a 37°C water bath for 16 hours. After incubation, 10 μL of trifluoroacetic acid (0.1%, v / v) and 118 μL of acetonitrile (100%) were added to stop the reaction. These samples were filtered through a hydrophilic polyvinylidene fluoride membrane filter (Millipore, Billerica, MA) with a pore size of 0.22 μm. Samples were stored at -20°C prior to UPLC-MS analysis.

Embodiment 2

[0031] High-dimensional LC-MS data generated from copolymer-1 samples

[0032] LC / MS data from 7 replicate samples from 2 different sources of the Copolymer-1 run, including a Copolymer-1 sample and a negative control (NC), both of which appear to be similar ( Figure 1a Copolymer-1 sample and 1b negative control), which indicated greater reproducibility between their individual 7 replicates. Comparing the LC-MS data of the copolymer-1 sample and 10 batches of Kepasone, an average score of greater than 95% was obtained, which means that the copolymer-1 sample and Kepasone have similar digested peptide composition . This can also be observed from the LC / MS data between these 11 runs ( Figure 1c ). When comparing 10 batches of Copaxone with one replicate of the negative control, there were several distinct peaks within the first 7 min ( Figure 1d ), where Copolymer-1 had negligible peaks in this region, indicating that certain digested peptides were only detected in Kepaso...

Embodiment 3

[0034] Similarity Evaluation by Hypothesis Testing

[0035] Statistical hypothesis testing is a method of statistical inference, usually applied in the comparison of 2 or more data sets. In the testing method, a statistical hypothesis is a testable hypothesis based on observations of a process modeled by a set of random variables. The inventors developed a hypothesis testing method to analyze high-dimensional LC-MS data to evaluate the degree of similarity between a reference drug and a generic. A feature of the hypothesis testing method proposed by the inventors is that all differences in data points between two sample groups are considered.

[0036] To first evaluate the feasibility of this method, 10 batches of Kepasson were randomly divided into two groups of 5 batches and their data points were used for the developed sum of squares test. Shows H for 0.0056 (p-value 0 was rejected, and different batches of Kepasone were significantly similar ( Figure 2a ). The invent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention develops a hypothesis testing approach to analyze the high-dimensional LC-MS data to assess the extent of similarity between a reference drug and generics.

Description

[0001] Cross References to Related Applications [0002] This application claims from U.S. Provisional Patent Application Serial No. 62726342 filed September 3, 2018 (hereinafter referred to as US62726342) and U.S. Nonprovisional (Utility) Patent Application Serial No. 16 / 530544 filed August 2, 2019 (hereinafter referred to as is the priority of US16 / 530544). The entire contents of US62726342 and US16 / 530544 are incorporated herein by reference. Background technique [0003] Glatiramer acetate (GA), a complex heterogeneous mixture of synthetic polypeptides, has been approved by the U.S. Food and Drug Administration (FDA) as an immunomodulatory drug for the treatment of relapsing-remitting multiple sclerosis (relapsing-remitting multiple sclerosis). remitting multiple sclerosis), relapsing-remitting multiple sclerosis is the most common disabling neurological disease in young adults. [0004] Glatiramer acetate (GA) is Kepasone @ (COPAXONE @ ) (Teva Pharmaceutical Industrie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): G01N33/68G01N30/72G01N1/40G01N30/06G01N30/88
CPCG01N33/6848G16B40/10G16C20/70G16C20/20G16C60/00
Inventor林隆晟廖宝琦
OwnerSCINOPHARM TAIWAN LTD